Fig. 4From: Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growthCD34-selected cells were incubated for several hours with daratumumab, BRIC229 or both and then plated in progenitor cell assays to assess their function. Pre-incubation did not diminish colony production compared to controls (mean ± SD)Back to article page